[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370526-105":59,"doc-detail-370526-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","progmodule-a-novel-computational-framework-to-identify-mutation-driver-modules-for-predicting-cancer-prognosis-and-immunotherapy-response","ProgModule - A novel computational framework to identify mutation driver modules for predicting cancer prognosis and immunotherapy response","","Cancer originates from dysregulated cell proliferation driven by driver gene mutations. Although many algorithms exist to infer genomic mutational signatures, they frequently face high computational complexity and limited clinical utility. ProgModule is presented as an advanced computational framework that identifies mutation driver modules for prognosis and immunotherapy response prediction. It introduces the Prognosis-Related Mutually Exclusive Mutation (PRMEM) score to balance exclusive mutation coverage with mutation-combination mechanisms critical for outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/progmodule-a-novel-computational-framework-to-identify-mutation-driver-modules-for-predicting-cancer-prognosis-and-immunotherapy-response/370526/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/progmodule-a-novel-computational-framework-to-identify-mutation-driver-modules-for-predicting-cancer-prognosis-and-immunotherapy-response/370526.png","ImageObject",300,407,{"name":92,"@type":93},"WPS_1786070896","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does ProgModule address in cancer genomics research?","Question",{"text":112,"@type":113},"Existing algorithms for identifying genomic mutational signatures are often computationally complex and limited in clinical applicability. ProgModule targets the need to identify mutation driver modules that support prognosis and immunotherapy response prediction.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does ProgModule improve detection of mutation driver modules?",{"text":117,"@type":113},"ProgModule introduces the Prognosis-Related Mutually Exclusive Mutation (PRMEM) score, optimizing the balance between exclusive mutation coverage and incorporating mutation combination mechanisms relevant to cancer prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What outputs and validation does the paper report for ProgModule?",{"text":121,"@type":113},"Across BLCA and HNSC cohorts, ProgModule identifies driver modules that stratify patients into distinct prognostic subgroups, and combining modules functions as an effective prognostic biomarker. Extended analyses across diverse cancers show robust prognostic performance and stability, and suggest driver modules better predict immunotherapeutic benefit than existing signatures.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370526,1791224442,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Li et al. Journal of Translational Medicine (2025) 23:518  \n[https://doi.org/10.1186/s12967-025-06497-0](https://doi.org/10.1186/s12967-025-06497-0)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nProgModule: A novel computational framework to identify mutation driver modules for predicting cancer prognosis and immunotherapy response  \nXiangmei Li 1†, Bingyue Pan 1†, Xilong Zhao 1†, Yinchun Su2, Jiyin Lai 1, Siyuan Li 1, Yalan He 1, Jiashuo Wu 1 and Junwei Han 1*  \nAbstract  \nBackground Cancer originates from dysregulated cell proliferation driven by driver gene mutations. Despite numerous algorithms developed to identify genomic mutational signatures, they often suffer from high computational complexity and limited clinical applicability.  \nMethods Here, we presented ProgModule, an advanced computational framework designed to identify mutation driver modules for cancer prognosis and immunotherapy response prediction. In ProgModule, we introduced the Prognosis-Related Mutually Exclusive Mutation (PRMEM) score, which optimizes the balance between exclusive mutation coverage and the incorporation of mutation combination mechanisms critical for cancer prognosis.  \nResults Applying to BLCA and HNSC cohorts, ProgModule successfully identified driver modules that stratify patients into distinct prognostic subgroups, and the combination of these modules could serve as an effective prognostic biomarker. Extending our method to diverse cancers, ProgModule presented robust prognostic performance and stability across model parameters, including stopping criteria and network topology. Moreover, our analysis suggested that driver modules can predict immunotherapeutic benefit more effectively than existing signatures. Further analyses based on published CRISPR data indicated that genes within these modules may serve as potential therapeutic targets.  \nConclusions Altogether, ProgModule emerges as a powerful tool for identifying mutation driver modules as prognostic and immunotherapy response biomarkers, and genes within these modules may be used as potential therapeutic targets for cancer, offering new insights into precision oncology.  \nKeywords Mutually exclusive mutation, Driver module, Prognostic biomarkers, Immune checkpoint inhibitors, Therapeutic targets  \n†Xiangmei Li, Bingyue Pan and Xilong Zhao contributed equally to this work.  \n*Correspondence:  \nJunwei Han [hanjunwei@ems.hrbmu.edu.cn](hanjunwei@ems.hrbmu.edu.cn)  \n1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China  \n2Department of Neurobiology, Harbin Medical University, Harbin 150081, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nLi et al. Journal of Translational Medicine (2025) 23:518  \nBackground  \nCancer emerges through the accrual of somatic mutations, with driver mutations conferring a selective advantage that enables cells to circumvent normal growth regulation and evade apoptotic sign","cbCaibl3a19Lxgex","https://ap.wps.com/l/cbCaibl3a19Lxgex","pdf",9796799,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords","[{\"question\":\"What problem does ProgModule address in cancer genomics research?\",\"answer\":\"Existing algorithms for identifying genomic mutational signatures are often computationally complex and limited in clinical applicability. ProgModule targets the need to identify mutation driver modules that support prognosis and immunotherapy response prediction.\"},{\"question\":\"How does ProgModule improve detection of mutation driver modules?\",\"answer\":\"ProgModule introduces the Prognosis-Related Mutually Exclusive Mutation (PRMEM) score, optimizing the balance between exclusive mutation coverage and incorporating mutation combination mechanisms relevant to cancer prognosis.\"},{\"question\":\"What outputs and validation does the paper report for ProgModule?\",\"answer\":\"Across BLCA and HNSC cohorts, ProgModule identifies driver modules that stratify patients into distinct prognostic subgroups, and combining modules functions as an effective prognostic biomarker. Extended analyses across diverse cancers show robust prognostic performance and stability, and suggest driver modules better predict immunotherapeutic benefit than existing signatures.\"}]","ProgModule - A novel computational framework to identify mutation driver modules for predicting cancer prognosis and immunotherapy response | PDF",1790188970,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1bd555606074e7715fda1aebfa7f780.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a9da81649f2a772ba1c851b8de35cff.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c1adf81c7a2f4e6d1c5f920ef46f7d7.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d17cb46949228410413d2a58b6afd76d.webp",980,1306]